Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 2.51% vs 11.80% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 42.02% vs -20.70% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -44.05% vs -8.60% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -11.58% vs -15.77% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -0.32% vs -5.60% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 2.51% vs 11.80% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -15.83% vs -27.79% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 42.02% vs -20.70% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -53.14% vs -15.98% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -44.05% vs -8.60% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -9.13% vs -4.91% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -11.58% vs -15.77% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






